Reference
1. Verhamme K, Dieleman J, Bleumink G, Van der Lei J, Sturkenboom M, Panel TPEE. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care—the Triumph project. European urology. 2002;42(4):323-8.
2. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men aged 45–79 years: a population‐based study of 40 000 Swedish men. BJU international. 2004;94(3):327-31.
3. Malaeb BS, Yu X, McBean AM, Elliott SP. National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008). Urology. 2012;79(5):1111-7.
4. Stroup SP, Palazzi‐Churas K, Kopp RP, Parsons JK. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008. BJU international. 2012;109(1):84-7.
5. Gravas S, Cornu J, Gacci M, et al. Management of Non-neurogenic Male LUTS. EAU guidelines. 2020.
6. Han HH, Ko WJ, Yoo TK, et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology. 2014;84(3):675-80.
7. Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. The Journal of urology. 1997;157(2):600-3.
8. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. The Journal of urology. 2005;174(5):1887-91.
9. Hur WS, Kim JC, Kim HS, et al. Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia. Investigative and clinical urology. 2016 Nov;57(6):431-6. PubMed PMID: 27847917. Pubmed Central PMCID: Pmc5109790. Epub 2016/11/17. eng.
10. Cho MC, Ha SB, Oh S-J, Kim SW, Paick J-S. Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). World journal of urology. 2015;33(8):1173-80.
11. Naspro R, Bachmann A, Gilling P, et al. A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. European urology. 2009;55(6):1345-57.
12. Bostanci Y, Kazzazi A, Djavan B. Laser prostatectomy: holmium laser enucleation and photoselective laser vaporization of the prostate. Reviews in urology. 2013;15(1):1.
13. Cho MC, Kim HS, Lee CJ, Ku JH, Kim SW, Paick JS. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate. Urology. 2010 Jun;75(6):1460-6. PubMed PMID: 19963247. Epub 2009/12/08. eng.
14. Foster HE, Dahm P, Kohler TS, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Amendment 2019. 2019;202(3):592-8.
15. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37-49.
16. Choi HR, Chung W, Shim BS, et al. Translation Validity and Reliability of I-PSS Korean Version. 1996;37:659-65.
17. Weld KJ, Graney MJ, Dmochowski RR. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol. 2000 Apr;163(4):1228-33. PubMed PMID: 10737503. Epub 2000/03/29. eng.
18. Harris RL, Cundiff GW, Theofrastous JP, Bump RC. Bladder compliance in neurologically intact women. Neurourology and Urodynamics: Official Journal of the International Continence Society. 1996;15(5):483-8.
19. Bannowsky A, Wefer B, Braun PM, Jünemann K-PJWjou. Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test. 2008;26(6):623-6.
20. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. The Journal of urology. 2008;180(1):241-5.
21. Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European urology. 2013;64(1):118-40.
22. Siroky M. The aging bladder. Reviews in urology. 2004;6(Suppl 1):S3.
23. Sullivan MP, Yalla SVJTJou. Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. 1996;155(6):1995-2000.
24. Yokoyama O, Mita E, Ishiura Y, Nakamura Y, Nagano KL, Namiki M. Bladder compliance in patients with benign prostatic hyperplasia. Neurourology and urodynamics. 1997;16(1):19-27.
25. Liao LM, Schaefer W. Cross‐sectional and longitudinal studies on interaction between bladder compliance and outflow obstruction in men with benign prostatic hyperplasia. Asian journal of andrology. 2007;9(1):51-6.
26. Bellucci CH, Ribeiro WdO, Hemerly TS, et al. Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction. Prostate international. 2017;5(2):70-4.
27. Akino H, Gobara M, Okada K. Bladder dysfunction in patients with benign prostatic hyperplasia: relevance of cystometry as prognostic indicator of the outcome after prostatectomy. International journal of urology. 1996;3(6):441-7.
28. Kwon O, Lee H-E, Bae J, Oh JK, Oh S-J. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study. Urology. 2014;83(3):581-5.